Pneumonia Vaccine Market: High Prevalence of Pneumonia in Children Globally Contributes to the Growth of the Market

Pneumonia Vaccine Market: Introduction

  • Pneumonia can be defined as lung infection which affects the air sacs and fills them up with fluid or pus. Infants below the age of two years and adults over the age of 65 years are at the higher risk of acquiring pneumonia.

Read Report Overview -

  • Pneumococcal diseases are considered to be common among children and adults. Elderly population is significantly prone to these infections, which might even lead to death. Pneumonia vaccines are usually administered to children less than two years of age and to adults over 65 years of age.
  • Pneumonia vaccine aids in fighting and provides immunization against over 13 types of pneumococcal bacteria known to cause infection in the lungs

Request Brochure of Report -

Key Drivers and Restraints of Global Pneumonia Vaccine Market

  • The global annual incidence of pneumonia is considered to be over 150.7 million cases according to the WHO Child Health Epidemiology Reference Group. In addition, over 95% of all these cases are known to be occurring in the developing countries. Furthermore, over 150 million new cases of pneumonia are known to occur in children below five years of age, leading to nearly 20 million hospitalizations annually at a global level. This high prevalence of pneumonia in children globally contributes to the growth of the pneumonia vaccines market.
  • Growing geriatric population along with the increasing prevalence of pneumococcal infections, makes the aging population more prone to infections, contributing to the rise in demand for pneumonia vaccines.
  • Furthermore, people with weakened immune system, including people suffering from heart disease, diabetes, smokers, and heavy drinkers, are more likely to get pneumonia. Increase in the population with weakened immune system contributes to the demand for pneumonia vaccine aiding in the growth of the market.

Request for Analysis of COVID-19 Impact on Pneumonia Vaccine Market -

North America to Lead Global Pneumonia Vaccine Market

  • In terms of region, the global pneumonia vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global pneumonia vaccine market in 2018, owing to strong presence of leading market players, high prevalence of pneumonia, increasing government focus on immunization programs, and advancements in administration of vaccines  

Request for Custom Research -

  • Europe was the second largest market for pneumonia vaccine in 2018, followed by Asia Pacific. Asia Pacific is projected to be the fastest growing market for pneumonia vaccine, followed by Latin America and Middle East & Africa. Growing focus of the governments in countries in Asia on enhancing healthcare facilities, government initiatives, rising disposable income, and rapid economic development contribute to the growth of the pneumonia vaccine market in the region.

Pre Book Pneumonia Vaccine Market Report at

Key Manufacturers Operating in Global Pneumonia Vaccine Market

Leading players in the global pneumonia vaccine market are:

  • Glaxosmithkline plc.
  • LG Chem Ltd.
  • Merck & Co., Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Pnuvax Incorporated
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
  • SK Bioscience
  • Walvax Biotechnology Co., Ltd.

Browse More Trending Reports by Transparency Market Research:

Total Ankle Replacement Market:

Vitreoretinal Surgery Devices Market:

Incubators Market:

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453

Back to news